NCT05698511View on ClinicalTrials.gov

Neural and Physiological Correlates of Psychedelic Sub-states

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Psychedelic ExperiencesNeuroimagingHealthy Volunteers
Interventions
DRUG

Psilocybin

Multiple dosing of healthy volunteers with up to 25 mg psilocybin separated from each other by at least one week. Participants will be scanned before and after receiving psilocybin on each dosing day. Surveys will be performed on dosing days and after dosing.

Trial Locations (1)

94158

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

Robin Carhart-Harris, PhD, MA

OTHER